Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alterity Therapeutics Ltd.

www.pranabio.com

Latest From Alterity Therapeutics Ltd.

Execs On The Move, July 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership BioPharmaceutical

Appointments: Prana, Octapharma, ABPI, Gamida and Allergy Therapeutics

This week's roundup includes senior appointments by Prana Biotechnology, Octapharma, Silence Therapeutics and ABPI, in addition to board appointments by Gamida Cell and Allergy Therapeutics.

Appointments BioPharmaceutical

Australia’s Prana Misses Primary Endpoint In POC Alzheimer’s Disease Trial; Stock Tanks

Prana’s lead Alzheimer’s candidate fails both primary and secondary endpoints in Alzheimer’s proof-of-concept- trial, but the company still has hopes that an extension study will show a stronger signal.

BioPharmaceutical Australia

Australia’s Prana Biotech Phase II Data On Huntington’s Candidate Holds Investor Interest With More To Come

Australia’s Prana Biotechnology has Phase II clinical trial data on a potential Huntington’s disease therapy to sustain a surge in the share price over the past year with more possibly on the way for an Alzheimer’s therapy.

BioPharmaceutical Australia
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Prana Biotechnology Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Alterity Therapeutics Ltd.
  • Senior Management
  • Geoffrey P Kempler , Exec. Chmn. & CEO
    David Stamler, MD, CMO & SVP, Clinical Dev.
  • Contact Info
  • Alterity Therapeutics Ltd.
    Phone: (61) 3 9349 4906
    460 Bourke St.
    Level 3
    Melbourne, VIC 3000
    Australia
UsernamePublicRestriction

Register